share_log

Larimar Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deerfield Management Company, L.P.(34.82%),James E. Flynn(34.82%), etc.

Larimar Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-Deerfield Management Company, L.P.(34.82%),James E. Flynn(34.82%)等

美股SEC公告 ·  02/17 03:17
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息